Adverum Biotechnologies Return on Net Operating Assets Analysis

Adverum Biotechnologies, Inc. (ADVM)

4.36 +0.10 (+2.35%) USD | NASDAQ | Dec 08, 16:00

4.50 +0.14 (+3.21%) After-Hours: 20:00

View Return on Net Operating Assets for ADVM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Pfizer Inc.	Upgrade
Recursion Pharmaceuticals, Inc.	Upgrade
Quantum-Si, Inc.	Upgrade
X4 Pharmaceuticals, Inc.	Upgrade